← All Sponsors
SPONSOR

NovoCure GmbH

Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Metastatic Non-small Cell Lung CancerGlioblastoma
NCT06216301 Phase 3
Recruiting

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Metastatic Non-small Cell Lung Cancer
United States, Austria, Belgium View Trial →
NCT06556563 Phase 3
Recruiting

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Glioblastoma
United States, Czechia, France View Trial →